Table 2.

Univariate analysis of the impact of variables on relapse-free and overall survival in pediatric acute myeloid leukemia patients

Variable	Patients (n)	Relapse-free survival		Overall survival
		Median (months ± SD)	P	Median (months ± SD)	P
Cytogenetics
Favorable	35	Not reached	<0.001	Not reached	<0.001
Intermediate	52	12.6 ± 1.8		22.9 ± 2.1
Unfavorable	19	3.1 ± 0.5		9.8 ± 1.7
FAB classification
M1–M6	96	14.3 ± 2.2	0.01	36.2 ± 3.8	0.008
M7	10	7.9 ± 1.4		20.7 ± 2.5
MiR-100 expression
Low (<10.8)	36	12.9 ± 1.6	0.008	37.4 ± 3.1	0.006
High (≥10.8)	70	5.8 ± 0.8		22.7 ± 2.9

Abbreviations: SD, standard deviation; FAB, French–American–British; MiR-100, microRNA-100.